SciBase Sees Increased Investment from Major Shareholders

September 11, 2025
SciBase's main shareholders, Ribbskottet AB and Life Science Investment Fund, have each acquired 7.5 million shares in a recent block trade, strengthening their positions in the AI-based dermatology company.

SciBase, a leader in AI-based dermatology devices, has seen a significant increase in investment from its main shareholders. Announced in a press release, Ribbskottet AB and Life Science Investment Fund have each purchased approximately 7.5 million shares in a block trade. This transaction was conducted off the stock exchange from larger long-term owners.

Anders Bladh, CEO of Ribbskottet AB, expressed confidence in SciBase's growth and potential, citing the company's recent collaborations, including one with Castle Biosciences Inc. Jan Poulsen, CEO of Life Science Investment Fund, also highlighted the compelling investment opportunity presented by SciBase's current valuation.

SciBase specializes in early detection and prevention in dermatology, utilizing its Nevisense platform that combines AI and advanced EIS technology to enhance diagnostic accuracy. The company has been listed on the Nasdaq First North Growth Market since 2015.

We hope you enjoyed this article.

Consider subscribing to one of our newsletters like Life AI Weekly or Daily AI Brief.

Also, consider following us on social media:

Healthcare & Life Sciences AI AI Brief AI Brief (X)

More from: Life Sciences

09/11
Levita Magnetics Achieves AI-Guided Autonomous Surgery Milestone
09/11
Nayya Acquires Northstar, Launches AI Benefits Solution
09/11
314e Corporation Unveils DextractLM for Healthcare Document Processing
09/11
Safe AI in Medicaid Alliance Launched to Enhance AI Standards
09/11
Next-Gen Antibody Therapeutics Market to Reach $22.88 Billion by 2033

Subscribe to Life AI Weekly

Weekly coverage of AI applications in healthcare, drug development, biotechnology research, and genomics breakthroughs.

AI Token Webinar

Whitepaper

Stanford HAI’s 2025 AI Index Reveals Record Growth in AI Capabilities, Investment, and Regulation

The 2025 AI Index by Stanford HAI provides a comprehensive overview of the global state of artificial intelligence, highlighting significant advancements in AI capabilities, investment, and regulation. The report details improvements in AI performance, increased adoption in various sectors, and the growing global optimism towards AI, despite ongoing challenges in reasoning and trust. It serves as a critical resource for policymakers, researchers, and industry leaders to understand AI's rapid evolution and its implications.

Read more

You May Also Like